News and Comments

COULD AGENUS VACCINE FOR GLIOBLASTOMA BE ASSIGNED BREAKTHROUGH DESIGNATION?

  Tuesday, September 17, 2013

AGENUS (AGEN) has extraordinary news. A recent analysis from a Phase 2 trial in patients with newly diagnosed glioblastoma multiforme (GBM) treated with Prophage Series G-100 (HSPPC-96) in combination with the current standard of care (radiation and temozolomide) showed an almost 18 month median progression free survival (PFS), which represents a 160% increase versus current standard of care alone. The results confirm continuation of the positive trends from the Phase 2 HSPPC-96 newly diagnosed GBM trial first reported at the 81st American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in May 2013. More...

AGENUS OFFERS AN INVESTMENT OPPORTUNITY.

  Saturday, September 07, 2013

 More...


Recent Postings


Archive


Tags

NANTKWEST (NK) Tysabri Theravance Bio Pharma (TBPH) SUNESIS PHARMACEUTICALS (SNSS) Trastuzumab-DM1 OSI (OSIP) ADVENTRIX (ANX) Sanofi (SNY) TOKAI (TKAOI) KERYX (KERX) Galena (GALE) Incyte (INCY) Elan (ELN) Prosensa (RNA) Aimmune Therapeutics (AIMT) ARCA (ABIO) Intermune (ITMN) Vitae Pharmaceuticals (VTAE) Benlysta (belimumab) Intrexon (XON) Roche (ROCHE) Endometrial Cancer Onyx (ONXX) ImmunoGen (IMGN) BIOMARIN (BMRN) Sanofi (SNA) Amgen (AMGN) Merck (MRK) Pluristem (PSTI) Ariad (ARIA) Human Genome Sciences (HGSI) NEKTAR (NKTR)) Rapamune Regeneron (REGN) Jazz Pharmaceuticals (JAZZ) Anadys (ANDS) Herceptin Zerenex Agenus (AGEN C4 Therapeutics Bristol-Myers Squibb (BMY) Biogen Idec (BIIB) Sarepta (SRPT) Array Pharmaceuticals (ARRY) Ziofpharm (ZIOP) Valeant Pharmaceuticals International (VRX) Idenix (IDIX) Agenus (AGEN) Abbott Laboratories (ABT) JUNO (JUNO) Prolor Biotech (PBTH) CompuGen (CGEN) HALOZYME (HALO) Anacor (ANAC) AERIE PHARMACEUTICALS Micromet (MITI) Genentech Intercept (ICPT) SYNTA (SNTA) ABBVIE (ABBV) Theravance (THRX) Xoma (XOMA) Roche (RHHBY) ACADIA (ACAD) SERES THERAPEUTICS (MCRB) Revlimid (lenolidamide) Dynavax (DVAX) Multiple Myeloma Ionis (IONS) GUARDIAN HEALTH Inovio (INO) Alnylam (ALNY) KITE (KITE) Gilead (GILD) Cytokinetics (CYTK) Sanofi-Aventis (SAN) VANDA (VNDA) Human Longevity (HLI) Velcade (bortezomib) Sequenom (SQNM) Alder Biopharmaceuticals (ALDR) Seattle Genetics (SGEN) Exelixis (EXEL) REGULUS (RGLS) ZALTRAP™ Sangamo (SGMO) Auspex (ASPX) Dendreon (DNDN) IDERA (IDRA) Illumina (ILMN) Mirati Therapeutics (MRTX) ISIS (ISIS) Biocryst (BCRX) Vertex (VRTX) Ridaforolimus galapagos (GLPG) GlaxoSmithKline (GSK) Telaprevir